1. Home
  2. WVE vs VZLA Comparison

WVE vs VZLA Comparison

Compare WVE & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$12.65

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

VZLA

Vizsla Silver Corp.

HOLD

Current Price

$3.81

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
VZLA
Founded
2012
2017
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
VZLA
Price
$12.65
$3.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
2
Target Price
$30.44
$7.00
AVG Volume (30 Days)
3.2M
14.4M
Earning Date
03-03-2026
12-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,230,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
103.75
N/A
52 Week Low
$5.28
$1.69
52 Week High
$21.73
$7.19

Technical Indicators

Market Signals
Indicator
WVE
VZLA
Relative Strength Index (RSI) 41.05 33.23
Support Level $12.51 $3.60
Resistance Level $14.15 $4.25
Average True Range (ATR) 0.76 0.42
MACD -0.04 -0.22
Stochastic Oscillator 8.29 7.93

Price Performance

Historical Comparison
WVE
VZLA

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

Share on Social Networks: